<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39308964</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1178-7074</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>International journal of general medicine</Title><ISOAbbreviation>Int J Gen Med</ISOAbbreviation></Journal><ArticleTitle>Effect of Tryptophan Restriction in the Therapy of Irritable Bowel Syndrome: a Systematic Review.</ArticleTitle><Pagination><StartPage>4141</StartPage><EndPage>4151</EndPage><MedlinePgn>4141-4151</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/IJGM.S474525</ELocationID><Abstract><AbstractText Label="BACKGROUND &amp; AIMS" NlmCategory="UNASSIGNED">The metabolic pathways of tryptophan (TRP) have been implicated in the pathophysiology of irritable bowel syndrome (IBS), positing that the strategic modulation of TRP consumption may exert regulatory effects on serotonin levels, consequently altering the clinical manifestation of IBS. This systematic review was meticulously orchestrated to evaluate the effect of TRP restriction on IBS.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A comprehensive search of the MEDLINE/PubMed, Cochrane Library, and Embase databases was conducted. Controlled trials that compared the efficacy of TRP restriction in IBS patients were scrutinized. The primary outcomes were gastrointestinal symptoms, quality of life, and pain, whereas the secondary outcomes included anxiety, mood, and safety. The risk of bias was meticulously assessed according to the guidelines recommended by the Cochrane Collaboration.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of five trials, enrolling 135 participants, were incorporated into the qualitative synthesis. Low-TRP intake attenuated gastrointestinal discomfort and enhanced psychological well-being in IBS patients, while the effects of acute TRP depletion were controversial. Safety data from one randomized controlled trial reported no occurrence of adverse events.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">This systematic review suggests that moderating, rather than depleting, TRP intake may potentially be a feasible and safe adjunctive treatment for patients with IBS. Future research incorporating a high-quality study design and consensus on clinical outcome measurements for IBS is warranted.</AbstractText><CopyrightInformation>&#xa9; 2024 Wang et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, The Affiliated Taian City Central Hospital of Qingdao University, Taian, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Peilin</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Bingjie</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qingcai</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, The Affiliated Taian City Central Hospital of Qingdao University, Taian, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Hongwei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Int J Gen Med</MedlineTA><NlmUniqueID>101515487</NlmUniqueID><ISSNLinking>1178-7074</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute tryptophan depletion</Keyword><Keyword MajorTopicYN="N">irritable bowel syndrome</Keyword><Keyword MajorTopicYN="N">reduced tryptophan diet</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList><CoiStatement>The authors declare that there are no financial or other relationships that might lead to a conflict of interest of the present article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>7</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>7</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>5</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39308964</ArticleId><ArticleId IdType="pmc">PMC11414632</ArticleId><ArticleId IdType="doi">10.2147/IJGM.S474525</ArticleId><ArticleId IdType="pii">474525</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dothel G, Barbaro MR, Di Vito A, et al. New insights into irritable bowel syndrome pathophysiological mechanisms: contribution of epigenetics. J Gastroenterol. 2023;58(7):605&#x2013;621. doi:10.1007/s00535-023-01997-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00535-023-01997-6</ArticleId><ArticleId IdType="pmc">PMC10307698</ArticleId><ArticleId IdType="pubmed">37160449</ArticleId></ArticleIdList></Reference><Reference><Citation>Staudacher HM, Black CJ, Teasdale SB, et al. Irritable bowel syndrome and mental health comorbidity - approach to multidisciplinary management. Nat Rev Gastroenterol Hepatol. 2023;20(9):582&#x2013;596. doi:10.1038/s41575-023-00794-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-023-00794-z</ArticleId><ArticleId IdType="pmc">PMC10237074</ArticleId><ArticleId IdType="pubmed">37268741</ArticleId></ArticleIdList></Reference><Reference><Citation>Camilleri M, Zhernakova A, Bozzarelli I, D&#x2019;Amato M. Genetics of irritable bowel syndrome: shifting gear via biobank-scale studies. Nat Rev Gastroenterol Hepatol. 2022;19(11):689&#x2013;702. doi:10.1038/s41575-022-00662-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-022-00662-2</ArticleId><ArticleId IdType="pubmed">35948782</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian S, Zhang H, Chen S, et al. Global research progress of visceral hypersensitivity and irritable bowel syndrome: bibliometrics and visualized analysis. Front Pharmacol. 2023;14:1175057. doi:10.3389/fphar.2023.1175057</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2023.1175057</ArticleId><ArticleId IdType="pmc">PMC10185792</ArticleId><ArticleId IdType="pubmed">37201020</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H, Zhang C, Zhang J, Duan L. &#x201d;Sentinel or accomplice&#x201d;: gut microbiota and microglia crosstalk in disorders of gut-brain interaction. Protein Cell. 2023;14(10):726&#x2013;742. doi:10.1093/procel/pwad020</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/procel/pwad020</ArticleId><ArticleId IdType="pmc">PMC10599645</ArticleId><ArticleId IdType="pubmed">37074139</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Y, Wang X, Huang S, et al. Low-level inflammation, immunity, and brain-gut axis in IBS: unraveling the complex relationships. Gut Microbes. 2023;15(2):2263209. doi:10.1080/19490976.2023.2263209</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2023.2263209</ArticleId><ArticleId IdType="pmc">PMC10549202</ArticleId><ArticleId IdType="pubmed">37786296</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner DM, Ladewski AM, Kinsinger SW. Development and current state of digital therapeutics for irritable bowel syndrome. Clin Gastroenterol Hepatol. 2023.</Citation><ArticleIdList><ArticleId IdType="pubmed">37743035</ArticleId></ArticleIdList></Reference><Reference><Citation>Camilleri M. Diagnosis and treatment of irritable bowel syndrome: a review. JAMA. 2021;325(9):865&#x2013;877. doi:10.1001/jama.2020.22532</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22532</ArticleId><ArticleId IdType="pubmed">33651094</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue C, Li G, Zheng Q, et al. Tryptophan metabolism in health and disease. Cell Metab. 2023;35(8):1304&#x2013;1326. doi:10.1016/j.cmet.2023.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2023.06.004</ArticleId><ArticleId IdType="pubmed">37352864</ArticleId></ArticleIdList></Reference><Reference><Citation>Mawe GM, Hoffman JM. Serotonin signalling in the gut--functions, dysfunctions and therapeutic targets. Nat Rev Gastroenterol Hepatol. 2013;10(8):473&#x2013;486. doi:10.1038/nrgastro.2013.105</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrgastro.2013.105</ArticleId><ArticleId IdType="pmc">PMC4048923</ArticleId><ArticleId IdType="pubmed">23797870</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna-Jairala I, Drossman DA. Central neuromodulators in irritable bowel syndrome: why, how, and when. Am J Gastroenterol. 2024;119(7):1272&#x2013;1284. doi:10.14309/ajg.0000000000002800</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000002800</ArticleId><ArticleId IdType="pmc">PMC11208063</ArticleId><ArticleId IdType="pubmed">38595149</ArticleId></ArticleIdList></Reference><Reference><Citation>Chojnacki C, B&#x142;o&#x144;ska A, Konrad P, et al. Changes in tryptophan metabolism on serotonin and kynurenine pathways in patients with irritable bowel syndrome. Nutrients. 2023;15(5):1262. doi:10.3390/nu15051262</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15051262</ArticleId><ArticleId IdType="pmc">PMC10005076</ArticleId><ArticleId IdType="pubmed">36904262</ArticleId></ArticleIdList></Reference><Reference><Citation>Chojnacki C, Medrek-Socha M, Blonska A, et al. A reduced tryptophan diet in patients with diarrhoea-predominant irritable bowel syndrome improves their abdominal symptoms and their quality of life through reduction of serotonin levels and its urinary metabolites. Int J Mol Sci. 2022;23(23):15314. doi:10.3390/ijms232315314</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232315314</ArticleId><ArticleId IdType="pmc">PMC9738361</ArticleId><ArticleId IdType="pubmed">36499643</ArticleId></ArticleIdList></Reference><Reference><Citation>Fila M, Chojnacki J, Pawlowska E, et al. Kynurenine pathway of tryptophan metabolism in migraine and functional gastrointestinal disorders. Int J Mol Sci. 2021;22(18):10134. doi:10.3390/ijms221810134</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221810134</ArticleId><ArticleId IdType="pmc">PMC8469852</ArticleId><ArticleId IdType="pubmed">34576297</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilkens TO, Honig A, van Nieuwenhoven MA, et al. Acute tryptophan depletion affects brain-gut responses in irritable bowel syndrome patients and controls. Gut. 2004;53(12):1794&#x2013;1800. doi:10.1136/gut.2004.041657</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.2004.041657</ArticleId><ArticleId IdType="pmc">PMC1774304</ArticleId><ArticleId IdType="pubmed">15542517</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordin E, Hellstr&#xf6;m PM, Vuong E, et al. IBS randomized study: fODMAPs alter bile acids, phenolic- and tryptophan metabolites, while gluten modifies lipids. Am J Physiol Regul Integr Comp Physiol. 2023;325(3):R248&#x2013;r259. doi:10.1152/ajpregu.00016.2023</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.00016.2023</ArticleId><ArticleId IdType="pubmed">37399002</ArticleId></ArticleIdList></Reference><Reference><Citation>Plantinga AM, Kamp KJ, Wu Q, et al. Exploration of associations among dietary tryptophan, microbiome composition and function, and symptom severity in irritable bowel syndrome. Neurogastroenterol Motil. 2023;35(5):e14545. doi:10.1111/nmo.14545</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.14545</ArticleId><ArticleId IdType="pmc">PMC10953042</ArticleId><ArticleId IdType="pubmed">36780542</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodoory VC, Khasawneh M, Black CJ, Ford AC. Assessing diagnostic performance of modifications to the Rome IV criteria for irritable bowel syndrome. Clin Gastroenterol Hepatol. 2024;22(9):1942&#x2013;1943. doi:10.1016/j.cgh.2024.02.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2024.02.012</ArticleId><ArticleId IdType="pubmed">38423348</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindfors P, Axelsson E, Engstrand K, et al. Online education is non-inferior to group education for irritable bowel syndrome: a randomized trial and patient preference trial. Clin Gastroenterol Hepatol. 2021;19(4):743&#x2013;751.e1. doi:10.1016/j.cgh.2020.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2020.04.005</ArticleId><ArticleId IdType="pubmed">32289541</ArticleId></ArticleIdList></Reference><Reference><Citation>Vork L, Keszthelyi D, van Kuijk SMJ, et al. Patient-specific stress-abdominal pain interaction in irritable bowel syndrome: an exploratory experience sampling method study. Clin Transl Gastroenterol. 2020;11(7):e00209. doi:10.14309/ctg.0000000000000209</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ctg.0000000000000209</ArticleId><ArticleId IdType="pmc">PMC7386351</ArticleId><ArticleId IdType="pubmed">32764210</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung WK, Wu JC, Liang SM, et al. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial. Am J Gastroenterol. 2006;101(7):1574&#x2013;1580. doi:10.1111/j.1572-0241.2006.00576.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1572-0241.2006.00576.x</ArticleId><ArticleId IdType="pubmed">16863563</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastrofini GF, McFadden BA, Chandler AJ, et al. The effects of a brand-specific, hemp-derived cannabidiol product on physiological, biochemical, and psychometric outcomes in healthy adults: a double-blind, randomized clinical trial. J Int Soc Sports Nutr. 2024;21(1):2370430. doi:10.1080/15502783.2024.2370430</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15502783.2024.2370430</ArticleId><ArticleId IdType="pmc">PMC11195455</ArticleId><ArticleId IdType="pubmed">38904150</ArticleId></ArticleIdList></Reference><Reference><Citation>Devenney J, Hasan SS, Morris J, et al. Clinical trial: predictive factors for response to gut-directed hypnotherapy for refractory irritable bowel syndrome, a post hoc analysis. Aliment Pharmacol Ther. 2023;59(2):269&#x2013;277. doi:10.1111/apt.17790</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.17790</ArticleId><ArticleId IdType="pubmed">37927144</ArticleId></ArticleIdList></Reference><Reference><Citation>Savovi&#x107; J, Weeks L, Sterne JA, et al. Evaluation of the Cochrane collaboration&#x2019;s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation. Syst Rev. 2014;3(1):37. doi:10.1186/2046-4053-3-37</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-3-37</ArticleId><ArticleId IdType="pmc">PMC4022341</ArticleId><ArticleId IdType="pubmed">24731537</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan M, Wu J, Lee J, et al. The risk of bias of non-randomized observational studies in deep inferior epigastric perforator flap breast reconstruction: a systematic review using ROBINS-I. J Plast Reconstr Aesthet Surg. 2022;75(11):4096&#x2013;4105. doi:10.1016/j.bjps.2022.06.093</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjps.2022.06.093</ArticleId><ArticleId IdType="pubmed">36117133</ArticleId></ArticleIdList></Reference><Reference><Citation>Chojnacki C, Poplawski T, Blonska A, et al. The usefulness of the low-FODMAP diet with limited tryptophan intake in the treatment of diarrhea-predominant irritable bowel syndrome. Nutrients. 2023;15(8):1837. doi:10.3390/nu15081837</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15081837</ArticleId><ArticleId IdType="pmc">PMC10145220</ArticleId><ArticleId IdType="pubmed">37111056</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy PJ, Allen AP, O&#x2019;Neill A, et al. Acute tryptophan depletion reduces kynurenine levels: implications for treatment of impaired visuospatial memory performance in irritable bowel syndrome. Psychopharmacology. 2015;232(8):1357&#x2013;1371. doi:10.1007/s00213-014-3767-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00213-014-3767-z</ArticleId><ArticleId IdType="pubmed">25338777</ArticleId></ArticleIdList></Reference><Reference><Citation>van Nieuwenhoven MA, Kilkens TO. The effect of acute serotonergic modulation on rectal motor function in diarrhea-predominant irritable bowel syndrome and healthy controls. Eur J Gastroenterol Hepatol. 2012;24(11):1259&#x2013;1265. doi:10.1097/MEG.0b013e3283583cf5</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MEG.0b013e3283583cf5</ArticleId><ArticleId IdType="pubmed">22890209</ArticleId></ArticleIdList></Reference><Reference><Citation>Shufflebotham J, Hood S, Hendry J, et al. Acute tryptophan depletion alters gastrointestinal and anxiety symptoms in irritable bowel syndrome. Am J Gastroenterol. 2006;101(11):2582&#x2013;2587. doi:10.1111/j.1572-0241.2006.00811.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1572-0241.2006.00811.x</ArticleId><ArticleId IdType="pubmed">17029611</ArticleId></ArticleIdList></Reference><Reference><Citation>Hood SD, Bell CJ, Nutt DJ. Acute tryptophan depletion. Part I: rationale and methodology. Aust N Z J Psychiatry. 2005;39(7):558&#x2013;564. doi:10.1080/j.1440-1614.2005.01627.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/j.1440-1614.2005.01627.x</ArticleId><ArticleId IdType="pubmed">15996136</ArticleId></ArticleIdList></Reference><Reference><Citation>Young SN. Acute tryptophan depletion in humans: a review of theoretical, practical and ethical aspects. J Psychiatry Neurosci. 2013;38(5):294&#x2013;305. doi:10.1503/jpn.120209</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/jpn.120209</ArticleId><ArticleId IdType="pmc">PMC3756112</ArticleId><ArticleId IdType="pubmed">23428157</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Leitner DR, Hasegawa Y, Waldor MK. Peripheral serotonergic neurons regulate gut motility and anxiety-like behavior. Curr Biol. 2024;34(4):R133&#x2013;r134. doi:10.1016/j.cub.2023.12.072</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2023.12.072</ArticleId><ArticleId IdType="pmc">PMC10921988</ArticleId><ArticleId IdType="pubmed">38412819</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuji A, Ikeda Y, Yoshikawa S, et al. The tryptophan and kynurenine pathway involved in the development of immune-related diseases. Int J Mol Sci. 2023;24(6):5742. doi:10.3390/ijms24065742</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24065742</ArticleId><ArticleId IdType="pmc">PMC10051340</ArticleId><ArticleId IdType="pubmed">36982811</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo SK, Kwon B. Immune regulation through tryptophan metabolism. Exp Mol Med. 2023;55(7):1371&#x2013;1379. doi:10.1038/s12276-023-01028-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-023-01028-7</ArticleId><ArticleId IdType="pmc">PMC10394086</ArticleId><ArticleId IdType="pubmed">37394584</ArticleId></ArticleIdList></Reference><Reference><Citation>Michaudel C, Danne C, Agus A, et al. Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases. Gut. 2023;72(7):1296&#x2013;1307. doi:10.1136/gutjnl-2022-327337</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2022-327337</ArticleId><ArticleId IdType="pmc">PMC10314090</ArticleId><ArticleId IdType="pubmed">36270778</ArticleId></ArticleIdList></Reference><Reference><Citation>Su X, Gao Y, Yang R. Gut microbiota-derived tryptophan metabolites maintain gut and systemic homeostasis. Cells. 2022;11(15):2296. doi:10.3390/cells11152296</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11152296</ArticleId><ArticleId IdType="pmc">PMC9330295</ArticleId><ArticleId IdType="pubmed">35892593</ArticleId></ArticleIdList></Reference><Reference><Citation>Gros M, Gros B, Mesonero JE, Latorre E. Neurotransmitter dysfunction in irritable bowel syndrome: emerging approaches for management. J Clin Med. 2021;10(15):3429. doi:10.3390/jcm10153429</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10153429</ArticleId><ArticleId IdType="pmc">PMC8347293</ArticleId><ArticleId IdType="pubmed">34362210</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo M, Zhuang X, Tian Z, Xiong L. Alterations in short-chain fatty acids and serotonin in irritable bowel syndrome: a systematic review and meta-analysis. BMC Gastroenterol. 2021;21(1):14. doi:10.1186/s12876-020-01577-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12876-020-01577-5</ArticleId><ArticleId IdType="pmc">PMC7788881</ArticleId><ArticleId IdType="pubmed">33407171</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikander A, Rana SV, Prasad KK. Role of serotonin in gastrointestinal motility and irritable bowel syndrome. Clin Chim Acta. 2009;403(1&#x2013;2):47&#x2013;55. doi:10.1016/j.cca.2009.01.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2009.01.028</ArticleId><ArticleId IdType="pubmed">19361459</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreeja V, Jose A, Patel S, et al. Pharmacogenetics of selective serotonin reuptake inhibitors (SSRI): a serotonin reuptake transporter (SERT)-based approach. Neurochem Int. 2024;173:105672. doi:10.1016/j.neuint.2023.105672</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2023.105672</ArticleId><ArticleId IdType="pubmed">38157886</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin DC, Cao HL, Xu MQ, et al. Regulation of the serotonin transporter in the pathogenesis of irritable bowel syndrome. World J Gastroenterol. 2016;22(36):8137&#x2013;8148. doi:10.3748/wjg.v22.i36.8137</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v22.i36.8137</ArticleId><ArticleId IdType="pmc">PMC5037082</ArticleId><ArticleId IdType="pubmed">27688655</ArticleId></ArticleIdList></Reference><Reference><Citation>Colucci R, Blandizzi C, Bellini M, et al. The genetics of the serotonin transporter and irritable bowel syndrome. Trends Mol Med. 2008;14(7):295&#x2013;304. doi:10.1016/j.molmed.2008.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2008.05.001</ArticleId><ArticleId IdType="pubmed">18550438</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JM, Choi MG, Park JA, et al. Serotonin transporter gene polymorphism and irritable bowel syndrome. Neurogastroenterol Motil. 2006;18(11):995&#x2013;1000. doi:10.1111/j.1365-2982.2006.00829.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2982.2006.00829.x</ArticleId><ArticleId IdType="pubmed">17040410</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadi M, Tahmasebi Abdar H, Mollaei HR, et al. Serotonin transporter gene (SLC6A4) polymorphism and mucosal serotonin levels in southeastern Iranian patients with irritable bowel syndrome. Middle East J Dig Dis. 2017;9(1):26&#x2013;32. doi:10.15171/mejdd.2016.48</Citation><ArticleIdList><ArticleId IdType="doi">10.15171/mejdd.2016.48</ArticleId><ArticleId IdType="pmc">PMC5308131</ArticleId><ArticleId IdType="pubmed">28316763</ArticleId></ArticleIdList></Reference><Reference><Citation>Gershon MD. Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther. 2004;20(Suppl 7):3&#x2013;14. doi:10.1111/j.1365-2036.2004.02180.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2036.2004.02180.x</ArticleId><ArticleId IdType="pubmed">15521849</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiller R. Serotonergic agents and the irritable bowel syndrome: what goes wrong? Curr Opin Pharmacol. 2008;8(6):709&#x2013;714. doi:10.1016/j.coph.2008.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2008.07.003</ArticleId><ArticleId IdType="pubmed">18672092</ArticleId></ArticleIdList></Reference><Reference><Citation>Clav&#xe9; P. Treatment of IBS-D with 5-HT3 receptor antagonists vs spasmolytic agents: similar therapeutical effects from heterogeneous pharmacological targets. Neurogastroenterol Motil. 2011;23(12):1051&#x2013;1055. doi:10.1111/j.1365-2982.2011.01808.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2982.2011.01808.x</ArticleId><ArticleId IdType="pubmed">22093116</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamatani T, Fukudo S, Nakada Y, et al. Randomised clinical trial: minesapride vs placebo for irritable bowel syndrome with predominant constipation. Aliment Pharmacol Ther. 2020;52(3):430&#x2013;441. doi:10.1111/apt.15907</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.15907</ArticleId><ArticleId IdType="pmc">PMC7383621</ArticleId><ArticleId IdType="pubmed">32583907</ArticleId></ArticleIdList></Reference><Reference><Citation>Tordjman S, Chokron S, Delorme R, et al. Melatonin: pharmacology, functions and therapeutic benefits. Curr Neuropharmacol. 2017;15(3):434&#x2013;443. doi:10.2174/1570159X14666161228122115</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X14666161228122115</ArticleId><ArticleId IdType="pmc">PMC5405617</ArticleId><ArticleId IdType="pubmed">28503116</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Gu X, Li LX, et al. Microbial and metabolomic profiles in correlation with depression and anxiety co-morbidities in diarrhoea-predominant IBS patients. BMC Microbiol. 2020;20(1):168. doi:10.1186/s12866-020-01841-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12866-020-01841-4</ArticleId><ArticleId IdType="pmc">PMC7302156</ArticleId><ArticleId IdType="pubmed">32552668</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiha MG, Aziz I. Review article: physical and psychological comorbidities associated with irritable bowel syndrome. Aliment Pharmacol Ther. 2021;54(Suppl 1):S12&#x2013;s23. doi:10.1111/apt.16589</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.16589</ArticleId><ArticleId IdType="pubmed">34927759</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins TA, Nguyen JC, Polglaze KE, Bertrand PP. Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis. Nutrients. 2016;8(1):56. doi:10.3390/nu8010056</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu8010056</ArticleId><ArticleId IdType="pmc">PMC4728667</ArticleId><ArticleId IdType="pubmed">26805875</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourhamzeh M, Moravej FG, Arabi M, et al. The roles of serotonin in neuropsychiatric disorders. Cell Mol Neurobiol. 2022;42(6):1671&#x2013;1692. doi:10.1007/s10571-021-01064-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-021-01064-9</ArticleId><ArticleId IdType="pmc">PMC11421740</ArticleId><ArticleId IdType="pubmed">33651238</ArticleId></ArticleIdList></Reference><Reference><Citation>Martos D, Tuka B, Tanaka M, et al. Memory enhancement with kynurenic acid and its mechanisms in neurotransmission. Biomedicines. 2022;10(4):849. doi:10.3390/biomedicines10040849</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10040849</ArticleId><ArticleId IdType="pmc">PMC9027307</ArticleId><ArticleId IdType="pubmed">35453599</ArticleId></ArticleIdList></Reference><Reference><Citation>Inam ME, Fernandes BS, Salagre E, et al. The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a systematic review and meta-analysis of cerebrospinal fluid studies. Braz J Psychiatry. 2023;45(4):343&#x2013;355. doi:10.47626/1516-4446-2022-2973</Citation><ArticleIdList><ArticleId IdType="doi">10.47626/1516-4446-2022-2973</ArticleId><ArticleId IdType="pmc">PMC10668321</ArticleId><ArticleId IdType="pubmed">37127280</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Liu Z, Shen P, et al. Kynurenic acid ameliorates lipopolysaccharide-induced endometritis by regulating the GRP35/NF-&#x3ba;B signaling pathway. Toxicol Appl Pharmacol. 2022;438:115907. doi:10.1016/j.taap.2022.115907</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.taap.2022.115907</ArticleId><ArticleId IdType="pubmed">35123988</ArticleId></ArticleIdList></Reference><Reference><Citation>Donlon J, Kumari P, Varghese SP, et al. Integrative pharmacology in the treatment of substance use disorders. J Dual Diagn. 2024;20(2):132&#x2013;177. doi:10.1080/15504263.2023.2293854</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15504263.2023.2293854</ArticleId><ArticleId IdType="pubmed">38117676</ArticleId></ArticleIdList></Reference><Reference><Citation>Feh&#xe9;r E, Szatm&#xe1;ri I, Dud&#xe1;s T, et al. Structural evaluation and electrophysiological effects of some kynurenic acid analogs. Molecules. 2019;24(19):3502. doi:10.3390/molecules24193502</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules24193502</ArticleId><ArticleId IdType="pmc">PMC6803921</ArticleId><ArticleId IdType="pubmed">31561643</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillemin GJ. Quinolinic acid, the inescapable neurotoxin. Febs j. 2012;279(8):1356&#x2013;1365. doi:10.1111/j.1742-4658.2012.08485.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2012.08485.x</ArticleId><ArticleId IdType="pubmed">22248144</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng W, Wang Y, Liu ZQ, et al. Microglia activation contributes to quinolinic acid-induced neuronal excitotoxicity through TNF-&#x3b1;. Apoptosis. 2017;22(5):696&#x2013;709. doi:10.1007/s10495-017-1363-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10495-017-1363-5</ArticleId><ArticleId IdType="pubmed">28315174</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuentes IM, Christianson JA. Ion channels, ion channel receptors, and visceral hypersensitivity in irritable bowel syndrome. Neurogastroenterol Motil. 2016;28(11):1613&#x2013;1618. doi:10.1111/nmo.12979</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.12979</ArticleId><ArticleId IdType="pmc">PMC5123675</ArticleId><ArticleId IdType="pubmed">27781369</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrest CM, Gould SR, Darlington LG, Stone TW. Levels of purine, kynurenine and lipid peroxidation products in patients with inflammatory bowel disease. Adv Exp Med Biol. 2003;527:395&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pubmed">15206756</ArticleId></ArticleIdList></Reference><Reference><Citation>Chojnacki C, Konrad P, M&#x119;drek-Socha M, et al. Altered tryptophan metabolism in patients with recurrent functional abdominal pain. Pol Merkur Lekarski. 2022;50(295):5&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">35278289</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun Y, Zhang Q, Zhao W, et al. Relationship between the tryptophan-kynurenine pathway and painful physical symptoms in patients with major depressive disorder. J Psychosom Res. 2022;163:111069. doi:10.1016/j.jpsychores.2022.111069</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2022.111069</ArticleId><ArticleId IdType="pubmed">36335711</ArticleId></ArticleIdList></Reference><Reference><Citation>Z&#xe1;dori D, Veres G, Szal&#xe1;rdy L, et al. Alzheimer&#x2019;s disease: recent concepts on the relation of mitochondrial disturbances, excitotoxicity, neuroinflammation, and kynurenines. J Alzheimers Dis. 2018;62(2):523&#x2013;547. doi:10.3233/JAD-170929</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-170929</ArticleId><ArticleId IdType="pubmed">29480191</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Gan M, Li J, et al. Endogenous indole pyruvate pathway for tryptophan metabolism mediated by IL4I1. J Agric Food Chem. 2020;68(39):10678&#x2013;10684. doi:10.1021/acs.jafc.0c03735</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jafc.0c03735</ArticleId><ArticleId IdType="pubmed">32866000</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson GM. &#x201d;The quantitative determination of indolic microbial tryptophan metabolites in human and rodent samples: a systematic review&#x201d;. J Chromatogr B Analyt Technol Biomed Life Sci. 2021;1186:123008. doi:10.1016/j.jchromb.2021.123008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchromb.2021.123008</ArticleId><ArticleId IdType="pubmed">34735972</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott SA, Fu J, Chang PV. Microbial tryptophan metabolites regulate gut barrier function via the aryl hydrocarbon receptor. Proc Natl Acad Sci U S A. 2020;117(32):19376&#x2013;19387. doi:10.1073/pnas.2000047117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2000047117</ArticleId><ArticleId IdType="pmc">PMC7431026</ArticleId><ArticleId IdType="pubmed">32719140</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao K, Mu CL, Farzi A, Zhu WY. Tryptophan metabolism: a link between the gut microbiota and brain. Adv Nutr. 2020;11(3):709&#x2013;723. doi:10.1093/advances/nmz127</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/advances/nmz127</ArticleId><ArticleId IdType="pmc">PMC7231603</ArticleId><ArticleId IdType="pubmed">31825083</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahony SM, Clarke G, Borre YE, et al. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res. 2015;277:32&#x2013;48. doi:10.1016/j.bbr.2014.07.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2014.07.027</ArticleId><ArticleId IdType="pubmed">25078296</ArticleId></ArticleIdList></Reference><Reference><Citation>Anastassova N, Stefanova D, Hristova-Avakumova N, et al. New indole-3-propionic acid and 5-methoxy-indole carboxylic acid derived hydrazone hybrids as multifunctional neuroprotectors. Antioxidants. 2023;12(4):977. doi:10.3390/antiox12040977</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox12040977</ArticleId><ArticleId IdType="pmc">PMC10135567</ArticleId><ArticleId IdType="pubmed">37107353</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Zhang L, Wu T, et al. Indole-3-propionic acid improved the intestinal barrier by enhancing epithelial barrier and mucus barrier. J Agric Food Chem. 2021;69(5):1487&#x2013;1495. doi:10.1021/acs.jafc.0c05205</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jafc.0c05205</ArticleId><ArticleId IdType="pubmed">33356219</ArticleId></ArticleIdList></Reference><Reference><Citation>Ait Abdellah S, Gal C, Laterza L, et al. Effect of a multistrain probiotic on leaky gut in patients with diarrhea-predominant irritable bowel syndrome: a pilot study. Dig Dis. 2023;41(3):489&#x2013;499. doi:10.1159/000526712</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000526712</ArticleId><ArticleId IdType="pmc">PMC10906476</ArticleId><ArticleId IdType="pubmed">36007493</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M, Ma N, He T, et al. Tryptophan (Trp) modulates gut homeostasis via aryl hydrocarbon receptor (AhR). Crit Rev Food Sci Nutr. 2020;60(10):1760&#x2013;1768. doi:10.1080/10408398.2019.1598334</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398.2019.1598334</ArticleId><ArticleId IdType="pubmed">30924357</ArticleId></ArticleIdList></Reference><Reference><Citation>Han H, Safe S, Jayaraman A, Chapkin RS. Diet-host-microbiota interactions shape aryl hydrocarbon receptor ligand production to modulate intestinal homeostasis. Annu Rev Nutr. 2021;41(1):455&#x2013;478. doi:10.1146/annurev-nutr-043020-090050</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-nutr-043020-090050</ArticleId><ArticleId IdType="pmc">PMC8667662</ArticleId><ArticleId IdType="pubmed">34633858</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Tian P, Wang Z, et al. Indole acetic acid exerts anti-depressive effects on an animal model of chronic mild stress. Nutrients. 2022;14(23):5019. doi:10.3390/nu14235019</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14235019</ArticleId><ArticleId IdType="pmc">PMC9737131</ArticleId><ArticleId IdType="pubmed">36501051</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>